FIRM FIXED PRICENO SET ASIDE USED.
XLCARE PHARMACEUTICALS INC - NEW AWARD FOR LEVOTHYROXINE NA TABLETS WITH XLCARE PHARMACEUTICALS, INC. BASE YEAR ORDERING PERIOD IS JAN 27, 2025 THROUGH JAN 26, 2026 WITH FOUR ONE-YEAR OPTIONS
PIID: 36E79725D0004Solicitation ID: 36E79724R0020
Signed Date: Nov 20, 2025Effective Date: Jan 27, 2025
Vendor
XLCARE PHARMACEUTICALS INC
NAICS
325412
Signed Date
Nov 20, 2025
Key Details
Description
NEW AWARD FOR LEVOTHYROXINE NA TABLETS WITH XLCARE PHARMACEUTICALS, INC. BASE YEAR ORDERING PERIOD IS JAN 27, 2025 THROUGH JAN 26, 2026 WITH FOUR ONE-YEAR OPTIONS
Context & Analysis
On Nov 20, 2025, Department of Veterans Affairs to XLCARE PHARMACEUTICALS INC for new award for levothyroxine na tablets with xlcare pharmaceuticals, inc. base year ordering period is jan 27, 2025 through jan 26, 2026 with four one-year options. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 3 offers received. The procurement used a NO SET ASIDE USED. set-aside.
Contractor Information
Stay Updated
Get notified about new opportunities matching your interests.